Literature DB >> 21921842

Behavioral and toxicological effects of propofol.

Michael B Gatch1, Michael J Forster.   

Abstract

There is increasing concern about abuse of propofol, a widely-used surgical anesthetic and sedative that is currently not a controlled substance. The purpose of this study was to establish a rat model of the psychoactive effect of subanesthetic doses of propofol that could be useful for confirming abuse liability and for studying mechanisms of propofol abuse. Sprague-Dawley rats were trained to discriminate propofol (10 mg/kg, intraperitoneally) from vehicle (2% methylcellulose). Carisoprodol (100 mg/kg), chlordiazepoxide (10 mg/kg), and dizocilpine (0.1 mg/kg) were tested for substitution for the discriminative-stimulus effects of propofol (10 mg/kg), whereas pentylenetetrazol (10 mg/kg) was tested for antagonism of the discriminative-stimulus effects. Propofol (10 mg/kg) was tested for substitution in rats trained to discriminate carisoprodol from vehicle. Carisoprodol produced 59% propofol-appropriate responding, chlordiazepoxide produced 65% propofol-appropriate responding, and dizocilpine produced 34% propofol-appropriate responding. Pentylenetetrazol decreased propofol-appropriate responding to 41%. Propofol produced 52% carisoprodol-appropriate responding. Mortality rate during training of propofol (10 mg/kg) was 38%. Postmortem examination revealed cardiovascular abnormalities similar to those observed in propofol-infusion syndrome in humans. The results demonstrate that propofol can be trained as a discriminative stimulus. Its discriminative-stimulus effects were more similar to compounds promoting γ-aminobutyric acid-A receptor activity than to a compound inhibiting N-methyl-d-aspartate receptor activity. As propofol has discriminative-stimulus effects similar to known drugs of abuse, and occasions a high-mortality rate, its potential for continued abuse is of particular concern.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21921842      PMCID: PMC3175093          DOI: 10.1097/FBP.0b013e32834aff84

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  24 in total

Review 1.  Propofol infusion syndrome: a rare complication with potentially fatal results.

Authors:  Melissa M Zaccheo; Donald H Bucher
Journal:  Crit Care Nurse       Date:  2008-06       Impact factor: 1.708

2.  Propofol decreases stimulated dopamine release in the rat nucleus accumbens by a mechanism independent of dopamine D2, GABAA and NMDA receptors.

Authors:  D Schulte; L F Callado; C Davidson; P E Phillips; N Roewer; J Schulte am Esch; J A Stamford
Journal:  Br J Anaesth       Date:  2000-02       Impact factor: 9.166

3.  Comparison of the intravenous reinforcing effects of propofol and methohexital in baboons.

Authors:  E M Weerts; N A Ator; R R Griffiths
Journal:  Drug Alcohol Depend       Date:  1999-11-01       Impact factor: 4.492

Review 4.  The abuse potential of propofol.

Authors:  Courtney Wilson; Peter Canning; E Martin Caravati
Journal:  Clin Toxicol (Phila)       Date:  2010-03       Impact factor: 4.467

5.  Abuse liability of the anesthetic propofol: self-administration of propofol in rats under fixed-ratio schedules of drug delivery.

Authors:  M G LeSage; D Stafford; J R Glowa
Journal:  Psychopharmacology (Berl)       Date:  2000-12       Impact factor: 4.530

6.  GABA(A) positive modulator and NMDA antagonist-like discriminative stimulus effects of isoflurane vapor in mice.

Authors:  Keith L Shelton; Katherine L Nicholson
Journal:  Psychopharmacology (Berl)       Date:  2010-08-10       Impact factor: 4.530

7.  Pharmacological characterization of the discriminative stimulus of inhaled 1,1,1-trichloroethane.

Authors:  Keith L Shelton
Journal:  J Pharmacol Exp Ther       Date:  2010-02-01       Impact factor: 4.030

8.  Selectivity in generalization to GABAergic drugs in midazolam-trained baboons.

Authors:  Nancy A Ator
Journal:  Pharmacol Biochem Behav       Date:  2003-05       Impact factor: 3.533

9.  High-dose propofol triggers short-term neuroprotection and long-term neurodegeneration in primary neuronal cultures from rat embryos.

Authors:  M Berns; L Seeberg; M Schmidt; T Kerner
Journal:  J Int Med Res       Date:  2009 May-Jun       Impact factor: 1.671

10.  Carisoprodol-mediated modulation of GABAA receptors: in vitro and in vivo studies.

Authors:  Lorie A Gonzalez; Michael B Gatch; Cynthia M Taylor; Cathy L Bell-Horner; Michael J Forster; Glenn H Dillon
Journal:  J Pharmacol Exp Ther       Date:  2009-02-24       Impact factor: 4.030

View more
  5 in total

1.  [Life-threatening fentanyl and propofol addiction: interview with a survivor].

Authors:  C Maier; J Leclerc-Springer
Journal:  Anaesthesist       Date:  2012-07       Impact factor: 1.041

2.  [Deaths from propofol abuse : Survey of institutes of forensic medicine in Germany, Austria and Switzerland].

Authors:  C Maier; J Iwunna; M Tsokos; F Mußhoff
Journal:  Anaesthesist       Date:  2017-01-13       Impact factor: 1.041

3.  Contribution of the α5 GABAA receptor to the discriminative stimulus effects of propofol in rat.

Authors:  Benfu Wang; Kun Lv; Huifeng Liu; Yin Su; Hong Wang; Sicong Wang; Suhao Bao; Wen-Hua Zhou; Qing-Quan Lian
Journal:  Neuroreport       Date:  2018-03-21       Impact factor: 1.837

Review 4.  Neurobiology of Propofol Addiction and Supportive Evidence: What Is the New Development?

Authors:  Ming Xiong; Nimisha Shiwalkar; Kavya Reddy; Peter Shin; Alex Bekker
Journal:  Brain Sci       Date:  2018-02-22

Review 5.  Metabolic Profiles of Propofol and Fospropofol: Clinical and Forensic Interpretative Aspects.

Authors:  Ricardo Jorge Dinis-Oliveira
Journal:  Biomed Res Int       Date:  2018-05-24       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.